July 7 , 2006
This week during the first California Vioxx trial, a doctor testified that studies conducted prior to the FDAs approval of Vioxx indicated an increased risk of heart attacks and strokes for users.
Dr. Lemuel Moye, a doctor and biostatistics professor at the University of Texas, concluded that studies dating back to 1996 indicated that Vioxx carried a significantly higher risk of cardiovascular side effects. The FDA approved Vioxx in 1999. The drug was pulled from the market in September 2004 after one study found that cardiovascular risks doubled for patients taking Vioxx compared to those taking a placebo.
This testimony was introduced in the second week of Californias first Vioxx trial. This is the eighth Vioxx case to go to trial in the United States. Merck, the makers of Vioxx, face nearly 13,000 pending lawsuits filed on behalf of those who have been injured by Vioxx.
Contact us to learn more information about the dangers of Vioxx or to speak with a qualified attorney.
